ACOT2
Acyl-coenzyme A thioesterase 2, mitochondrial
Also known as: ACOT2_HUMAN, Mte1, ZAP128
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P49753
- Gene
- ACOT2
- Ensembl
- ENSG00000119673
- Chromosome
- 14
- Canonical length
- 483 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene encodes a member of the acyl-CoA thioesterase protein family, and is one of four acyl-CoA hydrolase genes located in a cluster on chromosome 14. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
Canonical amino-acid sequenceUniProt
483 residues, UniProt reviewed canonical sequence.
>P49753|ACOT2
1 MSNKLLSPHP HSVVLRSEFK MASSPAVLRA SRLYQWSLKS SAQFLGSPQL RQVGQIIRVP
61 ARMAATLILE PAGRCCWDEP VRIAVRGLAP EQPVTLRASL RDEKGALFQA HARYRADTLG
121 ELDLERAPAL GGSFAGLEPM GLLWALEPEK PLVRLVKRDV RTPLAVELEV LDGHDPDPGR
181 LLCQTRHERY FLPPGVRREP VRVGRVRGTL FLPPEPGPFP GIVDMFGTGG GLLEYRASLL
241 AGKGFAVMAL AYYNYEDLPK TMETLHLEYF EEAMNYLLSH PEVKGPGVGL LGISKGGELC
301 LSMASFLKGI TAAVVINGSV ANVGGTLHYK GETLPPVGVN RNRIKVTKDG YADIVDVLNS
361 PLEGPDQKSF IPVERAESTF LFLVGQDDHN WKSEFYANEA CKRLQAHGRR KPQIICYPET
421 GHYIEPPYFP LCRASLHALV GSPIIWGGEP RAHAMAQVDA WKQLQTFFHK HLGGHEGTIP
481 SKVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACOT2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 115 nTPM
Expression across tissuesHPA
Tissue
- liver: 115 nTPM
- skeletal muscle: 107 nTPM
- heart muscle: 90 nTPM
- adipose tissue: 87 nTPM
- breast: 48 nTPM
- tongue: 47 nTPM
Single-cell type
- cardiomyocytes: 54 nCPM
- epididymal efferent duct absorptive cells: 52 nCPM
- epididymal principal cells: 41 nCPM
- megakaryocytes: 37 nCPM
- adipocytes: 36 nCPM
- epididymal efferent duct ciliated cells: 35 nCPM
Immune cell
- T-reg: 31 nTPM
- gdT-cell: 22 nTPM
- myeloid DC: 22 nTPM
- memory CD4 T-cell: 20 nTPM
- naive CD8 T-cell: 20 nTPM
- naive CD4 T-cell: 18 nTPM
Brain region
- thalamus: 25 nTPM
- choroid plexus: 23 nTPM
- basal ganglia: 18 nTPM
- cerebral cortex: 18 nTPM
- hippocampal formation: 18 nTPM
- amygdala: 18 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.33
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.7
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acyl-CoA metabolic process
- fatty acid metabolic process
- long-chain fatty acid metabolic process
- very long-chain fatty acid metabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Acyl-CoA thioester hydrolase/bile acid-CoA amino acid N-acetyltransferase
- BAAT/Acyl-CoA thioester hydrolase C-terminal
- Acyl-CoA thioesterase, long chain
- Alpha/Beta hydrolase fold
- Acyl-CoA thioester hydrolase/BAAT, N-terminal
- Acyl-CoA thioester hydrolase/BAAT N-terminal region
- BAAT / Acyl-CoA thioester hydrolase C terminal
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACOT2 as an antibody target. Whether an autoantibody or antibody against ACOT2 could matter depends on whether native ACOT2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACOT2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACOT2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...